Anti-BAIP2 [CA-A10-2]
Invented at IFOM-IEO
- Datasheet
- References (2)
- Inventor Info
Info
| Applications | IF WB |
| Antigen/Gene or Protein Targets | Brain speciļ¬c angiogenesis inhibitor 1 associated protein 2 |
| Reactivity | Human and Mouse |
| Relevance | Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672. |
| Host | Mouse |
| Myeloma Used | Sp2/0 |
| Research Area | Cell Type or Organelle Marker, Neurobiology, Protein Degradation |
References: 2 entries
Disanza et al. 2006. Nat Cell Biol. 8(12):1337-47. PMID: 17115031.
Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex.
Europe PMC ID: 17115031
Add a reference
References: 2 entries
Disanza et al. 2006. Nat Cell Biol. 8(12):1337-47. PMID: 17115031.
Regulation of cell shape by Cdc42 is mediated by the synergic actin-bundling activity of the Eps8-IRSp53 complex.
Add a reference
